SciVision Biotech Inc. (TPE:1786)
Taiwan · Delayed Price · Currency is TWD 46.30
+0.40 (0.87%)
Sep 8, 2026, 1:30 PM CST
SciVision Biotech Market Cap
SciVision Biotech has a market cap or net worth of 3.43 billion as of September 8, 2026. Its market cap has decreased by -46.66% in one year.
Market Cap
3.43B
Enterprise Value
3.19B
Revenue
889.15M
Ranking
n/a
PE Ratio
19.32
Stock Price
46.30
ChartMarket Cap Chart
Since December 29, 2010, SciVision Biotech's market cap has increased from 1.23B to 3.43B, an increase of 179.58%. That is a compound annual growth rate of 6.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 3.43B | -34.47% |
| Dec 31, 2025 | 5.24B | -29.80% |
| Dec 31, 2024 | 7.47B | 42.10% |
| Dec 29, 2023 | 5.25B | 46.46% |
| Dec 30, 2022 | 3.59B | 9.27% |
| Dec 30, 2021 | 3.28B | -12.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 7.10B |
| Pacific Hospital Supply | 5.66B |
| Formosa Optical Technology | 5.50B |
| St.Shine Optical | 4.97B |
| Bionime | 4.53B |
| ICARES Medicus | 3.67B |
| Maxigen Biotech | 3.43B |
| Nang Kuang Pharmaceutical | 3.22B |